知镜 Cognispect · 医学文献与研究工作台

Association between CYP11B2 rs1799998 genetic variant with essential hypertension and antihypertensive response.

Abdelrazaq D, Jarrar Y, Alhawari H, Zihlif M.
Personalized medicine · 2025-12-26 · PMID 41451765

文献摘要

Background Essential hypertension (EH) is influenced by genetic and environmental factors. The CYP11B2 gene, encoding aldosterone synthase, plays a major role in blood pressure regulation. This study investigated the association of the CYP11B2 -344C/T (rs1799998) variant with EH in Jordanians and evaluated its influence on response to amlodipine and valsartan. Methods A case-control study was conducted involving 309 Jordanian participants (154 hypertensive patients and 155 normotensive controls). Genotyping was performed using PCR-RFLP. Blood pressure (BP) was recorded before and after 1 month of treatment with either 80 mg valsartan or 10 mg amlodipine. Results Genotype frequencies (TT: 32.0%, TC: 50.5%, CC: 17.5%) and T allele frequency (57.28%) did not differ significantly between hypertensive and control groups ( p > 0.05). No association was found between rs1799998 and EH. Both valsartan and amlodipine significantly reduced BP ( p p = 0.028). Conclusion The CYP11B2 -344C/T variant was not associated with EH in Jordanians, but it was associated with amlodipine response. Further studies with larger sample size are needed to validate these findings.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。